Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms

Published:2017-04-07 Issue:5 Volume:34 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Chang Yu-Cheng,Lin Huan-Chau,Chiang Yi-Hao,Chen Caleb Gon-Shen,Huang Ling,Wang Wei-Ting,Cheng Chun-Chia,Lin Johnson,Chang Yi-Fang,Chang Ming-Chih,Hsieh Ruey-Kuen,Chen Shu-Jen,Lim Ken-Hong^ORCID,Kuo Yuan-Yeh

Funder

Ministry of Science and Technology, Taiwan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-017-0944-z.pdf

Reference19 articles.

1. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144–8.

2. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365(9464):1054–61.

3. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweg JR, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med. 2005;352(17):1779–90.

4. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell. 2005;7(4):387–97.

5. Klampfl T, Gisslinger H, Harutyunyan AS, Nivarthi H, Rumi E, Milosevic JD, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369(25):2379–90.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Two Novel Genetic Variants Involved in the Oxygen Sensing Pathway in JAK2-unmutated Erythrocytosis;Biochemical Genetics;2024-04-03

2. Molecular Genetic Profile of Myelofibrosis: Implications in the Diagnosis, Prognosis, and Treatment Advancements;Cancers;2024-01-25

3. Molecular testing in myeloproliferative neoplasms;Diagnostic Molecular Pathology;2024

4. Obesity and Leukemia: Biological Mechanisms, Perspectives, and Challenges;Current Obesity Reports;2023-12-30

5. Molecular landscape of the JAK2 gene in chronic myeloproliferative neoplasm patients from the state of Amazonas, Brazil;Biomedical Reports;2023-10-23